Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital ...
Hosted on MSN19h
Blood Sugar After Eating—What Are Good Numbers? A Clinical Expert Speaks
Knowing healthy postprandial glucose values is a worthwhile target to get healthier. A Cleveland Clinic expert shares the sweet spot and tips to keep your blood sugar steady.
verywellhealth1h
How to Recognize and Treat an Allergic Reaction in Babies and Infants
An allergic reaction in babies can range from mild to life-threatening. Here’s how to tell if your child is having an ...
FDA limits toxic lead in some baby foods
The Food and Drug Administration has set maximum levels for lead in baby foods like jarred fruits and vegetables, yogurts and dry cereal ...
The Lancet15h
Long-term VEDOKIDS results: implications for practice and research
The multicentre, prospective, cohort study by Ohad Atia and colleagues1 on the long-term efficacy and safety of maintenance vedolizumab in paediatric patients with inflammatory bowel disease (IBD) ...
Endocrinology Advisor15h
Childhood Diabetes Incidence, Burden Remain Substantial
Childhood diabetes incidence had increased since 1990, mortality and DALYs had decreased, and cases were projected to decrease.
Hosted on MSN22h
Ultragenyx’s Evkeeza secures EU approval for young children with rare cholesterol disorder
The decision follows a positive recommendation received from the Committee for Medicinal Products for Human Use (CHMP) in ...